Showing 3351-3360 of 3897 results for "".
- Online Care May Be As Effective as In-Person Care for Psoriasishttps://practicaldermatology.com/news/online-care-may-be-as-effective-as-in-person-care-for-psoriasis/2457574/Teledermatology may be as effective as seeing a doctor in person when it comes to improving the symptoms of psoriasis, according to a new study in JAMA Network Open. “Patients with chronic skin diseases need ongoing care, and depending on where they live, their access to de
- Dermira's Qbrexa Cloth Now Available for Primary Axillary Hyperhidrosishttps://practicaldermatology.com/news/dermiras-qbrexa-cloth-now-available-for-primary-axillary-hyperhidrosis/2457582/Dermira, Inc.'s Qbrexa (glycopyrronium) cloth is now available for prescribing to treat primary axillary hyperhidrosis. The new therapy is available in retail and community pharmacies nationwide. In June 2018, QBREXZA, a once-daily, prescription anticholinergic, was FDA approved to treat adul
- Research Identifies Disparities in Outpatient Dermatologic Carehttps://practicaldermatology.com/news/research-identifies-disparities-in-outpatient-dermatologic-care/2457592/The odds of a black or Hispanic patient visiting an outpatient dermatologist are about half that of a white patient with the same skin condition, according to a new study in JAMA Dermatology. Patie
- XBiotech Adds Dr. Alice Gottlieb to its Scientific Advisory Boardhttps://practicaldermatology.com/news/xbiotech-adds-dr-alice-gottlieb-to-its-scientific-advisory-board/2457599/Alice Gottlieb, MD, PhD joined XBiotech Inc.'s Scientific Advisory Board (SAB). Dr. Alice Gottlieb is internationally recognized for her expertise and pioneering work in the development of biological therapies to treat skin diseases. Dr. Gottlieb has played key roles in the clinical eval
- By the Numbers: The Skin Cancer Foundation's Destination Healthy Skin Initiative Concludeshttps://practicaldermatology.com/news/by-the-numbers-the-skin-cancer-foundations-destination-healthy-skin-initiative-concludes/2457602/With a total of 1,243 free skin cancer screenings to its credit, The Skin Cancer Foundation’s mobile skin cancer education and screening programDestination: Healthy Skinhas concluded its second annual journey around the US. Fifty-three dermatologists volunteered to p
- FDA Clears Sebacia Microparticles for Laser-Based Acne Treatmenthttps://practicaldermatology.com/news/fda-clears-sebacia-microparticles-for-laser-based-acne-treatment/2457603/Sebacia Microparticles are now FDA-cleared for use in the treatment of acne. The clearance comes on the heels of a pivotal study demonstrating the clinical safety and efficacy of the micoparticles. Sebacia, Inc. had submitted its 510(k) submission to the FDA in June 2018. Sebacia Mic
- Bee Venom May Help Treat Eczemahttps://practicaldermatology.com/news/bee-venom-may-help-treat-eczema/2457619/Bee venom and its major component, melittin, may be effective treatments for atopic dermatitis, according to a British Journal of Pharmacology study. Through studies conducted in mice and in human cells, inv
- Mind the Gap: Disparity Between Urban and Rural Derms Widenshttps://practicaldermatology.com/news/mind-the-gap-disparity-between-urban-and-rural-derms-widens/2457618/The gap between dermatologists in urban and rural areas is widening across the United States, according to a new study of county-level data from 1995 to 2013 in JAMA Dermatology. Specifically, derm
- Castle Biosciences' DecisionDx-Melanoma Test Improved AJCC-Based Risk Prediction for Melanoma Recurrence, Metastasishttps://practicaldermatology.com/news/castle-biosciences-decisiondx-melanoma-test-improved-ajcc-based-risk-prediction-for-melanoma-recurrence-metastasis/2457664/Castle Biosciences, Inc’s. DecisionDx®-Melanoma test improved risk prediction beyond that using American Joint Committee on Cancer (AJCC) based staging, according to a new study presented at the DERM2018 NP/PA CME Conference held in Las Veg
- Dermatologist Named a Finalist for Inaugural FNIH Trailblazer Prize for Clinician-Scientistshttps://practicaldermatology.com/news/dermatologist-named-a-finalist-for-inaugural-fnih-trailblazer-prize-for-clinician-scientists/2457663/An oncodermatologist is in the running for the Foundation for the National Institutes of Health (FNIH) inaugural Trailblazer Prize for Clinician-Scientists. The three finalists are Daniel Bauer, MD, PhD, Harvard Medical School, Jaehyuk Choi, MD, PhD, Feinberg School of Medicine, North